Kimi Iguchi, See Remarks at Sage Therapeutics, Inc. (SAGE), sold 2,500 shares at $80.10 ($200K) on 2015-06-08, disclosed to the SEC on 2015-06-08.
Scheduled sale ($200k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SAGE | SELL | 2018-04-25 | $6.1M | — | Filing → |
| SAGE | SELL | 2017-01-13 | $539K | — | Filing → |
| SAGE | SELL | 2016-11-18 | $207K | — | Filing → |